PRODUCT DETAIL

Imatinib Sandoz 400 mg

Code

6929B

MA number

44/0496/15-S

Product Form:

tbl flm 30x400 mg (blis.PVC/PE/PVDC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EA	BCR-ABL tyrosine kinase inhibitors
L01EA01	Imatinib

Shelf life:

Container:

blister PVC/PE/PVDC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	09.12.2015
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
SPC:	SPC_Imatinib Sandoz 400 mg_03.2023.pdf
PIL:	PIL_Imatinib Sandoz 400 mg_03.2023.pdf
Safety feature	Yes
Data update:	09.03.2023